Abstract
Aim: The present study aimed to describe the use of ophthalmic and nasal naphazoline in the outpatient setting.
 Methodology: This was a retrospective study that includes reviewing the electronic prescriptions of naphazoline among outpatients in a public hospital in Alkharj.
 Results: During the study period of 6 months, 393 patients received naphazoline. Most of them were male patients (77.35%) and the age of 34.35% of them was between 20 and 29 years. The majority of the prsecriptions that contained naphazoline were prescribed by residents (99.75%). Most of the patients received naphazoline as nasal drops either alone (47.84%) or combined with chlorpheniramine (36.13%). The majority of the prescriptions were written by the emergency department (99.24%).
 Conclusion: The present study showed that naphazoline was commonly prescribed in Alkharj. Further studies are needed to explore the frequency and pattern of naphazoline use as well as to explore the frequency of prescribing other sympathomimetic vasoconstrictors in different settings.
Highlights
IntroductionEye redness is a condition that is caused by swollen blood vessels [1]
2.2 Inclusion and Exclusion CriteriaEye redness is a condition that is caused by swollen blood vessels [1]
Naphazoline is a sympathomimetic vasoconstrictor used for the symptomatic relief of redness and itching of the eye, and nasal congestion [3]
Summary
Eye redness is a condition that is caused by swollen blood vessels [1]. Naphazoline is a sympathomimetic vasoconstrictor used for the symptomatic relief of redness and itching of the eye, and nasal congestion [3]. It is a rapid acting imidazoline sympathomimetic vasoconstrictor of nasal or ocular artierioles [4,5]. Its actions are increased by combining it with other active ingredients in the same formulation as a synergistic effect [6,7,8,9,10]. It is commonly combined with diphenhydramine hydrochloride, pheniramine maleate, and chlorpheniramine maleate [6,7,8,9,10]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
